Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
140 participants
INTERVENTIONAL
2016-01-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
no use of stylet
Endotracheal intubation was performed 2 min after rocuronium injection without use of stylet with McGrath videolaryngoscope after endotracheal tube was rolled up circularly for 3 min
McGrath videolaryngoscope
without use of stylet
rocuronium
tracehal intubation was performed 2 min after rocuronium injection with McGrath videolaryngoscope
use of stylet
Endotracheal intubation was performed 2 min after rocuronium injection using a styletted endotracheal tube with McGrath videolaryngoscope
McGrath videolaryngoscope with Intubating stylet (Mallinckrodt)
use of stylet
rocuronium
tracehal intubation was performed 2 min after rocuronium injection with McGrath videolaryngoscope
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
McGrath videolaryngoscope
without use of stylet
McGrath videolaryngoscope with Intubating stylet (Mallinckrodt)
use of stylet
rocuronium
tracehal intubation was performed 2 min after rocuronium injection with McGrath videolaryngoscope
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* rapid sequence induction
* body mass index\> 35 kg/m2
* airway pathology
19 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ajou University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jong Yeop Kim
Associate profefssor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jong Yeop Kim
Role: STUDY_DIRECTOR
Ajou University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ajou University Hospital
Suwon, Gyeongki-do, South Korea
Ajou University Hospital
Suwon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AJIRB-MED-DE4-15-345
Identifier Type: -
Identifier Source: org_study_id